search
Back to results

Efficacy of Methods to Treat Multiple Gingival Recession Defects

Primary Purpose

Gingival Recession

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Coronally Advanced Flap
Intrasulcular Tunneling
Vestibular Incision Subperiosteal Tunnel Access (VISTA)
Leukocyte-Platelet Rich Fibrin (L-PRF)
Sponsored by
University of Southern California
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Gingival Recession

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Male and female individuals between ages of 18 to 70 years old
  • Multiple contiguous gingival recession defects on a minimum of two adjacent teeth, exhibiting 3mm or more recession on at least one of those teeth
  • No prior surgical treatment in the sites planned for therapy
  • Minimum of 2 mm of keratinized gingiva
  • Absence of cervical restorations extending to the CEJ
  • Miller class 1, 2 and 3 recession defects will be included
  • Availability to undergo treatment and return for follow up visits at specified post-operative intervals

Exclusion Criteria:

  • Molar teeth
  • Milller Class 4 recession defects
  • Pregnancy (Self-reported)
  • Smoking
  • Uncontrolled local or systemic diseases that affects wound healing (diabetes, autoimmune or inflammatory disorders)
  • Past history of systemic steroid use over 2 weeks within the last 2 years
  • Poor oral hygiene on a non-compliant individual
  • Ibuprofen Allergy/interlerance
  • Anticoagulant therapy (e.g. Warfarin, Plavix, etc.), will not be automatic exclusion but patients will be required to have INR test performed and have values between 2.0 to 3. Physician consultation will be requested to determine whether anticoagulant therapy can be discontinued for 3 days prior to surgery.
  • Objection to blood draw or application of blood products
  • Students and staff from USC Ostrow school of Dentistry will not be recruited for this study

Sites / Locations

  • University of Southern California

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

Experimental

Arm Label

Coronally Advanced Flap

Vestibular Incision Subperiosteal Tunnel Access (VISTA)

Intrasulcular tunneling

VISTA + Leukocyte-Platelet Rich Fibrin

Arm Description

Outcomes

Primary Outcome Measures

Complete root coverage
Complete coverage of the recession defect following surgery. It will be a binary outcome (Yes or No)

Secondary Outcome Measures

Clinical Attachment Level gain
Gain of clinical attachment defined by the distance between the cement-enamel junction to the depth of the periodontal pocket around the teeth measured in mm by a periodontal probe
% root coverage
Percentage of the denuded root surface which is covered following the procedure
Gingival Thickness Gain
Thickness of the gingival following the procedure
Gingival Volume Gain
The gingival volume gain following the procedure

Full Information

First Posted
April 18, 2017
Last Updated
June 24, 2019
Sponsor
University of Southern California
search

1. Study Identification

Unique Protocol Identification Number
NCT03124329
Brief Title
Efficacy of Methods to Treat Multiple Gingival Recession Defects
Official Title
An Open Prospective Randomized Controlled Clinical Trial to Examine the Efficacy of Methods to Treat Multiple Gingival Recession Defects
Study Type
Interventional

2. Study Status

Record Verification Date
June 2019
Overall Recruitment Status
Terminated
Why Stopped
The PI left the institution
Study Start Date
May 1, 2017 (Actual)
Primary Completion Date
June 19, 2019 (Actual)
Study Completion Date
June 19, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Southern California

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Rationale: Treatment of gingival recession defects requires coronal advancement of the gingival margin due to patient esthetic demand, tooth sensitivity and improvement of tooth prognosis, which can be accomplished either through a flap procedure or through a tunnel. It will be desirable to determine the efficacy of Vestibular Incision Subperiosteal Tunnel Access (VISTA) to Coronally Advanced Flap (CAF) procedure and intrasulcular tunneling. Another aspect of the study is to determine whether autologous concentrate of platelets and leukocytes (leukocyte-platelet-rich fibrin; L-PRF) has equivalent efficacy to connective tissue autologous graft harvested from the palate. The overall objective of this study is to evaluate the effectiveness of therapeutic modalities for the treatment of multiple gingival recession defects. The study is designed as a prospective, randomized controlled clinical trial. Four groups will be compared: Group 1: Coronally Advanced Flap (CAF) Group 2: VISTA Group 3: Intrasulcular tunneling (IST) Group 4: VISTA + L-PRF Each of the groups will be treated without any graft material in order to examine the efficacy of coronal advancement and periodontal root coverage without the confounding variable of graft material. These techniques don't require any additional graft if there is adequate amount of keratinized gingiva The study population will be patients who present to Advanced Graduate Program in Periodontology at the University of Southern California, USA, and are deemed to require treatment of multiple gingival recession defects. A total sample of 100 participants (23 participants per group) will provide a two sided test of means with 80% power at alpha of 0.05. The calculation was carried out using PASS Version 12 (Hintze, J. (2014). NCSS, LLC. Kaysville, Utah.) The study duration will be 1 year. Follow-up visits after the surgery will occur after 3 days , 7 days and at weeks 3, 6, 12, 24, 36 and 52. These follow up visits consistent with standard of care follow up for gingival recession treatment and there will be no additional costs to the participant. The Primary Outcome variable is complete root coverage; the Secondary Outcome Variables are clinical attachment level (CAL) gain, changes in gingival thickness and volume and the Tertiary Outcomes are aesthetic outcomes, postoperative pain and Patient satisfaction survey

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gingival Recession

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
25 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Coronally Advanced Flap
Arm Type
Experimental
Arm Title
Vestibular Incision Subperiosteal Tunnel Access (VISTA)
Arm Type
Experimental
Arm Title
Intrasulcular tunneling
Arm Type
Experimental
Arm Title
VISTA + Leukocyte-Platelet Rich Fibrin
Arm Type
Experimental
Intervention Type
Procedure
Intervention Name(s)
Coronally Advanced Flap
Intervention Description
Coronally advanced flap will be performed. Briefly, sulcular incisions will be made. Oblique incisions will be made on each papilla requiring root coverage. In the region coronal to the mucogingival junction (MGJ), mucoperiosteal flap will be elevated. Apical to the MGJ, sharp dissection will be performed to the periosteum allowing split-thickness flap elevation to be performed. Epithelium is removed from the papillae adjacent to the recession and the flap is coronally positioned and stabilized with interproximal sutures and apico-coronal interrupted sutures to close the vertical releasing incisions.
Intervention Type
Procedure
Intervention Name(s)
Intrasulcular Tunneling
Intervention Description
Initial sulcular incisions are made and small, contoured blades and mini curettes are used to create the recipient pouches and tunnels. The tunnel will be subperiosteal in location. The incision is extended to one adjacent tooth both mesially and distally. This incision maintains the full height and thickness of the gingival component and enables access beneath the buccal gingiva. The connective tissue beyond the mucogingival line will be dissected and free the buccal flap from its insertions to the bone around each tooth. Muscle fibers and any remaining collagen fibers on the inner aspect of the flap, which prevent the buccal gingiva from being moved coronally, are cut. The papillae are kept intact and undermined to maintain their integrity and carefully released from the underlying bone, which allows the coronal positioning of the papillae. An envelope, full-thickness pouch, and tunnel are created and extended apically beyond the mucogingival line by blunt dissection
Intervention Type
Biological
Intervention Name(s)
Vestibular Incision Subperiosteal Tunnel Access (VISTA)
Intervention Description
The VISTA approach begins with a Vestibular Incision Subperiosteal Tunnel Access. Through this incision a subperiosteal tunnel is created, exposing the facial osseous plate and root dehiscence. This tunnel will be extended at least one or two teeth beyond the teeth requiring root coverage to mobilize gingival margins and facilitate coronal repositioning. Additionally, the subperiosteal tunnel is extended interproximally under each papilla as far as the embrasure space permits, without making any surface incisions through the papilla. The mucogingival complex is then advanced coronally and stabilized in the new position with the coronally anchored suturing technique, which entails placing a horizontal mattress suture apical to the gingival margin of each tooth. The suture is tied to position the knot at the midcoronal point of the facial aspect of each tooth, which is secured with help of composite resin to prevent apical relapse of the gingival margin during initial stages of healing.
Intervention Type
Device
Intervention Name(s)
Leukocyte-Platelet Rich Fibrin (L-PRF)
Intervention Description
Immediately prior to surgery, 72 mL of blood should be drawn from each patient by venipuncture of the antecubital vein and collected in a sterile glass test tube without any anticoagulant. Tubes should be centrifuged at 2,700 rpm for 12 minutes within 2 minutes after blood draw. For individuals on anti-coagulant therapy or supplements to interfere with coagulation, centrifugation will be for 18 minute. After centrifugation, each L-PRF clot will be separated from the portion of red blood cells (red thrombus), obtaining a fibrin clot with a red small portion in order to include the "buffy" coat richer in leucocytes. The L-PRF clot is condensed and modeled on a sterile surgical plate. L-PRF will be used within 60 minutes after the preparation.
Primary Outcome Measure Information:
Title
Complete root coverage
Description
Complete coverage of the recession defect following surgery. It will be a binary outcome (Yes or No)
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Clinical Attachment Level gain
Description
Gain of clinical attachment defined by the distance between the cement-enamel junction to the depth of the periodontal pocket around the teeth measured in mm by a periodontal probe
Time Frame
12 months
Title
% root coverage
Description
Percentage of the denuded root surface which is covered following the procedure
Time Frame
12 months
Title
Gingival Thickness Gain
Description
Thickness of the gingival following the procedure
Time Frame
12 months
Title
Gingival Volume Gain
Description
The gingival volume gain following the procedure
Time Frame
12 months
Other Pre-specified Outcome Measures:
Title
Patient-reported outcomes
Description
Includes: pain experienced within the mouth as a whole, pain experienced while drinking beverages, pain experienced while chewing, pain experienced in the morning, Pain experienced throughout the day, Pain experienced at night, Edema experienced after the surgery all measure with the use of a Visual Analogue Scale
Time Frame
3 days
Title
objective esthetic assessment
Description
This score evaluates five variables: level of the gingival margin, marginal tissue contour, soft tissue texture, mucogingival junction alignment, and gingival color. Because complete root coverage is the primary treatment goal, and the other variables were considered secondary, the value assigned for root coverage is 60% of the total score, whereas 40% is assigned to the other four variables.
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male and female individuals between ages of 18 to 70 years old Multiple contiguous gingival recession defects on a minimum of two adjacent teeth, exhibiting 3mm or more recession on at least one of those teeth No prior surgical treatment in the sites planned for therapy Minimum of 2 mm of keratinized gingiva Absence of cervical restorations extending to the CEJ Miller class 1, 2 and 3 recession defects will be included Availability to undergo treatment and return for follow up visits at specified post-operative intervals Exclusion Criteria: Molar teeth Milller Class 4 recession defects Pregnancy (Self-reported) Smoking Uncontrolled local or systemic diseases that affects wound healing (diabetes, autoimmune or inflammatory disorders) Past history of systemic steroid use over 2 weeks within the last 2 years Poor oral hygiene on a non-compliant individual Ibuprofen Allergy/interlerance Anticoagulant therapy (e.g. Warfarin, Plavix, etc.), will not be automatic exclusion but patients will be required to have INR test performed and have values between 2.0 to 3. Physician consultation will be requested to determine whether anticoagulant therapy can be discontinued for 3 days prior to surgery. Objection to blood draw or application of blood products Students and staff from USC Ostrow school of Dentistry will not be recruited for this study
Facility Information:
Facility Name
University of Southern California
City
Los Angeles
State/Province
California
ZIP/Postal Code
90089
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The intra-oral clinical photography, CBCT scans, study models and clinical data will be shared with other investigators for data analysis.

Learn more about this trial

Efficacy of Methods to Treat Multiple Gingival Recession Defects

We'll reach out to this number within 24 hrs